Table 3.
Secondary outcomes: patient self-reported 12-Item Short-Form Health Survey (physical and mental) scores at baseline and 6- and 12-month follow-up for the 117 patients included in the primary analysis.
| Secondary outcomes | Patient, n (%) | PHS-12a, mean (SD) | MHS-12b, mean (SD) | PHS-12; estimate, mean (95% CI)c | MHS-12; estimate, mean (95% CI)c | |||||||
| ATPd | ||||||||||||
|
|
Mean trajectory
|
|||||||||||
|
|
|
Baseline | 52 (83) | 39.6 (11.6) | 34.4 (9.6) | —e | — | |||||
|
|
|
Follow-up at 6 months | 51 (81) | 39.5 (11.5) | 36.7 (9.8) | — | — | |||||
|
|
|
Follow-up at 12 months | 42 (67) | 38.7 (11.5) | 38.2 (9.1) | — | — | |||||
|
|
Change from baseline | |||||||||||
|
|
|
6 months versus baseline | 43 (68) | −1.4 (8.8) | 2 (11.9) | −1.2 (−3.9 to 11.61.6) | 2.5 (−0.7 to 5.7) | |||||
|
|
|
12 months versus baseline | 33 (52) | 0.3 (9.3) | 3.7 (12.5) | 0.1 (−3.0 to 3.2) | 3.6 (−0.003 to 7.1) | |||||
| STPf | ||||||||||||
|
|
Mean trajectory
|
|||||||||||
|
|
|
Baseline | 45 (83) | 43.4 (10.4) | 31.7 (8.9) | — | — | |||||
|
|
|
Follow-up at 6 months | 41 (76) | 41.3 (10.5) | 36 (11.1) | — | — | |||||
|
|
|
Follow-up at 12 months | 28 (52) | 43.9 (9.4) | 34.3 (10.4) | — | — | |||||
|
|
Change from baseline | |||||||||||
|
|
|
6 months versus baseline | 34 (63) | −1.8 (11.4) | 5.1 (10.4) | −2.1 (−5 to 0.8) | 4.7 (1.4 to 8.1) | |||||
|
|
|
12 months versus baseline | 24 (44) | −1.1 (8.9) | 5 (9.9) | 0.001 (−3.3 to 3.3) | 3.7 (-0.2 to 7.5) | |||||
| ATP versus STP, difference at baseline | — | — | — | −9.5 (−32.5 to 13.6) | −2.7 (−24.1 to 18.8) | |||||||
| ATP versus STP, difference at follow-up at 6 months | — | — | — | −8.6 (−31.5 to 14.4) | −4.9 (−26.1 to 16.3) | |||||||
| ATP versus STP, difference at follow-up at 12 months | — | — | — | −9.4 (−32.5 to 13.8) | −2.8 (−24.4 to 18.8) | |||||||
| ATP versus STP, difference in follow-up at 6 months versus baseline differences | — | — | — | 0.9 (−3.1 to 4.9) | −2.2 (−6.9 to 2.5) | |||||||
| ATP versus STP, difference in follow-up at 12 months versus baseline differences | — | — | — | 0.1 (−4.4 to 4.7) | −0.1 (−5.3 to 5.1) | |||||||
aPHS-12: 12-Item Short-Form Health Survey Physical Health Summary; range 0-100, higher is better physical health.
bMHS-12: 12-Item Short-Form Health Survey Mental Health Summary; range 0-100, higher is better mental health.
cFrom mixed-effects linear regression models adjusted for study site, consulting psychiatrist, and language of the interview as well as clustering due to patient and primary care physician.
dATP: asynchronous telepsychiatry.
eNot available.
fSTP: synchronous telepsychiatry.